We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Launches Late-Stage Trials of Blood Thinners for COVID-19
NIH Launches Late-Stage Trials of Blood Thinners for COVID-19
The National Institutes of Health (NIH) launched two phase 3 trials yesterday, evaluating different types of blood thinners to treat COVID-19 patients.